Top Tweets for #TNBCDX
Announcing a link between B-cell and T-cell immune infiltration and improved survival rates in #breastcancer survivors. These are integrated into #HER2DX and #TNBCDX, enhancing their role in guiding clinical decisions for HER2+ and TNBC.
More: https://t.co/eOG6ExVTv4
#TNBCDX at #SABCS24 too!!
@JavierCortesMD about optimizing the prognosis of patients with TNBC
#breastcancer
El nostre CSO i cofundador @prat_aleix parla a @SEGREcom sobre #TNBCDX i el càncer de mama triple negatiu, destacant la importància d’ajudes com la @BecaMartaS. Llegeix l’article aquí (en català):
https://t.co/BzIrgySpca
On this day, we reaffirm our commitment to advancing research, innovation, and #precisiononcology. Every breakthrough brings us closer to better outcomes for #patients. #PrecisionOncology #Innovation #BreastCancerAwarenessMonth #HER2DX #DNADX #TNBCDX
This week brings exciting news:
Just published in @Annals_Oncology! ⭐️
Introducing #TNBCDX – a genomic test that predicts outcomes for early-stage TNBC patients treated with neoadjuvant taxane-based therapy, with or without pembrolizumab. Read it here: https://t.co/eECsEXwQkD
📢Development and validation of #TNBCDX a new genomic biomarker for early-stage triple-negative breast cancer with an without pembrolizumab.
Published in @Annals_Oncology
https://t.co/ylFMtdatFx
@prat_aleix @VHIO @Laiapb @fara_bm @RevealGenomics
🎉 Celebrating 4 amazing years today! This milestone is just the beginning, thanks to our visionary leadership, committed team, and everyone who trusts us. We are dedicated to transforming cancer care to benefit patients. 🚀 #breastcancer #HER2DX #DNADX #TNBCDX
@DrLisaCarey highlights #TNBCDX and mentions #HER2DX: We're revolutionizing #precisiononcology in #breastcancer with these cutting-edge tools! Exciting advancements are here, benefiting patients and shaping the future. 🚀 #ESMO24 #ESMO2024
Conclusions from Dr. Miguel Martin's presentation on #TNBCDX, the test that will transform the treatment landscape for Triple-Negative #breastcancer
#precisiononcology #esmo24 #ESMO2024
#TNBCDX is making an impact at #ESMO24 💡 The first genomic test for early-stage triple-negative #breastcancer shows a strong association with pCR, DDFS, and OS. Dr. Miguel Martin is presenting now. #precisiononcology
More info: https://t.co/Vza5FoZqpC
Across two independent validation studies with 418 patients, the #TNBCDX® scores showed a strong association with pathological complete response (pCR), distant disease-free survival (DDFS), and overall survival (OS).
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.1M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
109.1M followers
Narendra Modi
@narendramodi
106.9M followers
Rihanna
@rihanna
97.3M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.6M followers
KATY PERRY
@katyperry
86.9M followers
Taylor Swift
@taylorswift13
80.7M followers
Lady Gaga
@ladygaga
72.3M followers
Kim Kardashian
@kimkardashian
69.4M followers
Virat Kohli
@imvkohli
68.7M followers
YouTube
@youtube
68.6M followers
Bill Gates
@billgates
63.4M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.3M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
60M followers